With the increasing demands for temperature-sensitive supplies such as biomedicines, vaccines, and fresh perishable goods in both quantity and quality, aviation cold chain logistics has made significant developments in recent years as a mode of transportation with improved delivery times and safety. Notably, aviation cold chain logistics for pharmaceuticals has emerged as a crucial point for the sector to be competitive for global airlines and large air transport hubs providing the latest technology.
Two critical steps in the development of aviation cold chain logistics are the innovation and evolving of new temperature control technology, and the establishment of applicable operational procedures and standards. Fortunately, the World Health Organization (WHO), the International Air Transport Association (IATA), as well as government regulators and the aviation industry have achieved amazing accomplishments in these two areas with unrelenting coordinated efforts. IATA has elevated the operational and support capacities of the manufacturers, airports, airlines, freight forwarders, and logistics businesses concerned to a higher level with the creation of the CEIV Pharma certification.
The market currently prefers temperature controlled air cargo containers equipped with active technologies, such as compressor refrigeration and electric heating. The active technology controls temperature more precisely and more efficiently, and safeguards high value commodities, which need stringent temperature control during air transport.
However, due to the industry sector being in its infancy, it has been faced with several obstacles, such as limited existing manufacturers that can produce active temperature controlled air cargo containers and high costs, resulting in insufficient supply of containers.
Qingdao Haier Biomedical Co., Ltd. has initiated a deeper exploration of the aviation temperature control industry since 2020 because of its acute understanding of market needs and profound technology history in cold chain transport solutions. Haier Biomedical has successively established strategic cooperative relationships with China Southern Airlines Logistics, Russian Airbridge Cargo Airlines and created high-quality and high-standard air transport service scenarios.
Emerging equipment manufacturers represented by Haier Biomedical have injected new vitality into the development of the industry. Together delivering remarkable and cost-effective solutions to customers, while also contributing to the rapid growth of air pharma cold chain logistics and the global fight against COVID-19.
Founded in 2005, Haier Biomedical which started from the design, production and sales of cryogenic storage equipment for bio-medical industry is now a service provider for the digital medical infrastructure in the biosafety industry. The products and solutions have been installed in more than 120 countries worldwide. We have also established a strong relationship with some international organizations like the WHO and UNICEF based on long-term cooperation.
Jeff Jingzhong
Marketing Director-Temperature Control Solution
